放射線量管理製品の世界市場：放射線量トラッキング、モニタリング、解析ソフトウェア、コンサルティングサービス...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 STAKEHOLDERS 20

2 RESEARCH METHODOLOGY 21
2.1 RESEARCH APPROACH 21
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.4 MARKET SHARE ESTIMATION 27
2.5 ASSUMPTIONS FOR THE STUDY 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 33
4.1 GROWTH POTENTIAL OF THE RADIATION DOSE MANAGEMENT SYSTEMS MARKET 33
4.2 NORTH AMERICAN RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT 34
4.3 RADIATION DOSE MANAGEMENT MARKET: REGIONAL GROWTH OPPORTUNITIES 35
4.4 RADIATION DOSE MANAGEMENT MARKET: REGIONAL MIX 36
4.5 RADIATION DOSE MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS 36

5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 38
5.3 MARKET DYNAMICS 40
5.4 MARKET DRIVERS 40
5.4.1 GROWING REGULATORY, LEGISLATORY, AND ACCREDITATION REQUIREMENTS FOR RADIATION DOSE MANAGEMENT 40
5.4.2 INCREASING CONCERNS OVER RADIATION OVEREXPOSURE 41
5.4.3 GROWING AWARENESS AMONG STAKEHOLDERS AND INDUSTRY INITIATIVES FOR RADIATION DOSE MANAGEMENT 42
5.5 MARKET RESTRAINTS 43
5.5.1 LACK OF AWARENESS AMONG MEDICAL PROFESSIONALS AND LACK OF SKILLED OPERATORS 43
5.5.2 LOWER ADOPTION OF RADIATION DOSE MANAGEMENT SOFTWARE IN EMERGING MARKETS 43
5.6 MARKET OPPORTUNITIES 44
5.6.1 TECHNOLOGICAL ADVANCEMENTS 44
5.6.2 INTERVENTIONAL RADIOLOGY AND NUCLEAR MEDICINE 45
5.7 CHALLENGES 45
5.7.1 LACK OF BENCHMARKING FOR DOSE OPTIMIZATION ACROSS THE GLOBE 45

6 INDUSTRY INSIGHTS 47
6.1 INTRODUCTION 47
6.2 INDUSTRY TRENDS 47
6.3 PORTER’S FIVE FORCES ANALYSIS 48
6.3.1 THREAT OF NEW ENTRANTS 48
6.3.2 THREAT OF SUBSTITUTES 49
6.3.3 BARGAINING POWER OF SUPPLIERS 49
6.3.4 BARGAINING POWER OF BUYERS 49
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 50
6.4 STRATEGIC BENCHMARKING 50
6.4.1 PARTNERSHIPS, COLLABORATIONS, AND ACQUISITIONS: THE MOST WIDELY ADOPTED STRATEGY 50

7 GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT TYPE 52
7.1 INTRODUCTION 53
7.2 RADIATION DOSE MANAGEMENT SOFTWARE MARKET 54
7.2.1 RADIATION DOSE TRACKING, MONITORING, AND ANALYTICS SOFTWARE 56
7.2.2 POST-IMAGE PROCESSING SOFTWARE 58
7.3 RADIATION DOSE MANAGEMENT SERVICES MARKET 59
7.3.1 IMPLEMENTATION AND INTEGRATION SERVICES 61
7.3.2 SUPPORT AND MAINTENANCE SERVICES 62
7.3.3 EDUCATION & TRAINING SERVICES 63
7.3.4 CONSULTING SERVICES 64

8 GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION 66
8.1 INTRODUCTION 67
8.2 COMPUTED TOMOGRAPHY 69
8.3 FLUOROSCOPY AND INTERVENTIONAL IMAGING 70
8.4 NUCLEAR MEDICINE 72
8.5 RADIOGRAPHY AND MAMMOGRAPHY 73

9 GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY END USER 75
9.1 INTRODUCTION 76
9.2 HOSPITALS 78
9.3 DIAGNOSTIC CENTERS 80
9.4 RESEARCH INSTITUTES AND ACADEMIC MEDICAL CENTERS 81

10 RADIATION DOSE MANAGEMENT MARKET, BY REGION 82
10.1 INTRODUCTION 83
10.2 NORTH AMERICA 85
10.2.1 U.S. 89
10.2.2 CANADA 92
10.3 EUROPE 95
10.3.1 FRANCE 99
10.3.2 U.K. 102
10.3.3 ITALY 105
10.3.4 GERMANY 108
10.3.5 SPAIN 111
10.3.6 ROE 114
10.4 ASIA-PACIFIC 117
10.4.1 JAPAN 121
10.4.2 REST OF ASIA-PACIFIC 124
10.5 REST OF THE WORLD (ROW) 128
10.5.1 LATIN AMERICA 130
10.5.1 MIDDLE EAST AND AFRICA 133

11 COMPETITIVE LANDSCAPE 136
11.1 OVERVIEW 136
11.2 MARKET SHARE ANALYSIS 137
11.3 COMPETITIVE SITUATION AND TRENDS 139
11.3.1 AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND ALLIANCES 140
11.3.2 NEW PRODUCT LAUNCHES 141
11.3.3 MERGERS AND ACQUISITIONS 142
11.3.4 OTHER DEVELOPMENTS 143

12 COMPANY PROFILES 144
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 BAYER AG 145
12.2 GE HEALTHCARE 148
12.3 SECTRA AB 151
12.4 PACSHEALTH LLC 153
12.5 PHILIPS HEALTHCARE (PHILIPS) 155
12.6 AGFA HEALTHCARE 157
12.7 FUJIFILM HOLDINGS CORPORATION 159
12.8 MCKESSON CORPORATION 161
12.9 NOVARAD CORPORATION 163
12.10 TOSHIBA MEDICAL SYSTEMS CORPORATION 164
12.11 SIEMENS HEALTHCARE (SIEMENS AG) 167
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

13 APPENDIX 169
13.1 INSIGHTS OF INDUSTRY EXPERTS 169
13.2 DISCUSSION GUIDE 170
13.3 RECENT DEVELOPMENTS, BY MARKET PLAYER, 2012–2015 174
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 176
13.5 AVAILABLE CUSTOMIZATIONS 177
13.6 RELATED REPORTS 178